Covid-19: Johnson booster 85% effective against Omicron – South Africa study
JOHANNESBURG— A booster of US coronavirus vaccine Johnson & Johnson was 85 percent effective in preventing serious illness in areas where Omicron was dominant, a South African trial study indicated. The South African Medical Research Council conducte…